First Time Loading...

Livzon Pharmaceutical Group Inc
SZSE:000513

Watchlist Manager
Livzon Pharmaceutical Group Inc Logo
Livzon Pharmaceutical Group Inc
SZSE:000513
Watchlist
Price: 40.1 CNY 1.75% Market Closed
Updated: May 4, 2024

Livzon Pharmaceutical Group Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Livzon Pharmaceutical Group Inc
Cash from Financing Activities Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Livzon Pharmaceutical Group Inc
SZSE:000513
Cash from Financing Activities
-¥1.7B
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash from Financing Activities
-¥818.1m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash from Financing Activities
-¥789.1m
CAGR 3-Years
N/A
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash from Financing Activities
-¥1.8B
CAGR 3-Years
-124%
CAGR 5-Years
N/A
CAGR 10-Years
-36%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash from Financing Activities
-¥2.9B
CAGR 3-Years
1%
CAGR 5-Years
-22%
CAGR 10-Years
-25%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Cash from Financing Activities
¥365.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Livzon Pharmaceutical Group Inc's Cash from Financing Activities?
Cash from Financing Activities
-1.7B CNY

Based on the financial report for Dec 31, 2023, Livzon Pharmaceutical Group Inc's Cash from Financing Activities amounts to -1.7B CNY.

What is Livzon Pharmaceutical Group Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-47%

Over the last year, the Cash from Financing Activities growth was -130%. The average annual Cash from Financing Activities growth rates for Livzon Pharmaceutical Group Inc have been -47% over the past three years .